The demand for obesity drugs in India is surging as Eli Lilly and Novo Nordisk compete. A Pakistani startup sends prosthetics ...

The health sector is witnessing notable developments, including the rising demand for obesity drugs in India as Eli Lilly and ...

Reduced monthly costs for uninsured patients still amount to around $500. That can put the drugs out of reach for many.

As summer began and temperatures rose in June, so too did TV ad spending for Novo Nordisk’s Wegovy. | As summer began and ...

About 1 in 5 classified as overweight based on BMI alone considered to have obesity according to European society definition.

Doctors say the situation forces them to get creative in treating patients, but there’s hope that prices may fall more in the ...

Novo Nordisk (NVO) announced on Tuesday that it has submitted a new higher dose of its weight loss medication, Wegovy, to the European Medicines Agency for approval. The company is requesting approval ...

While Eli Lilly has struggled in the past year due to competitive pressures, the statistical winds may finally favor LLY ...